COMPASS Pathways plc (CMPS) Financial Statements (2026 and earlier)

Company Profile

Business Address 3RD FLOOR, 1 ASHLEY ROAD
CHESIRE, WA14 2DT
State of Incorp.
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) (USD)

3/31/2026
MRQ
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments149,608,000165,081,000220,198,000143,206,000273,243,000
Cash and cash equivalent149,608,000165,081,000220,198,000143,206,000273,243,000
Restricted cash and investments379,000389,000440,000175,000104,000
Receivables  1,109,0001,052,0001,652,0001,629,000
Prepaid expense3,434,00035,821,00040,658,00048,270,00021,953,000
Other current assets 5,580,000    
Other undisclosed current assets 32,489,000(1,109,000)(1,052,000)(1,652,000)(1,629,000)
Total current assets:191,490,000201,291,000261,296,000191,651,000295,300,000
Noncurrent Assets
Operating lease, right-of-use asset3,424,0002,006,0004,306,0002,006,0003,696,000
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization    617,000398,000
Deferred income tax assets3,751,0003,774,0003,336,0002,224,000766,000
Other noncurrent assets11,684,0006,595,0007,049,000327,000213,000
Other undisclosed noncurrent assets    469,000525,000
Total noncurrent assets:18,859,00012,375,00014,691,0005,643,0005,598,000
TOTAL ASSETS:210,349,000213,666,000275,987,000197,294,000300,898,000
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities22,009,00021,729,00014,038,00011,579,0008,968,000
Employee-related liabilities5,018,000
Accounts payable15,222,00012,283,0005,892,0004,761,0002,564,000
Accrued liabilities 6,787,0009,446,0008,146,0006,818,0001,386,000
Debt 17,523,0005,513,000   
Other liabilities 559,0001,325,0001,025,000656,000268,000
Other undisclosed current liabilities207,704,0005,449,0004,541,0003,361,0005,871,000
Total current liabilities:247,795,00034,016,00019,604,00015,596,00015,107,000
Noncurrent Liabilities
Long-term debt and lease obligation14,110,00024,652,000  1,379,000
Long-term debt, excluding current maturities14,110,00024,652,000   
Liabilities, other than long-term debt1,292,000303,0001,882,000418,000 
Operating lease, liability1,292,000303,0001,882,000418,0001,379,000
Other undisclosed noncurrent liabilities   28,757,000 (1,379,000)
Total noncurrent liabilities:15,402,00024,955,00030,639,000418,0001,379,000
Total liabilities:263,197,00058,971,00050,243,00016,014,00016,486,000
Equity
Equity, attributable to parent, including:(52,848,000)154,695,000225,744,000181,280,000284,412,000
Common stock973,000702,000   
Additional paid in capital783,562,000704,919,000621,645,000458,825,000444,750,000
Accumulated other comprehensive income (loss)(14,789,000)(16,194,000)(16,926,000)(16,867,000)8,840,000
Accumulated deficit(822,594,000)(534,732,000)(379,610,000)(261,146,000)(169,641,000)
Other undisclosed equity, attributable to parent   635,000468,000463,000
Total equity:(52,848,000)154,695,000225,744,000181,280,000284,412,000
TOTAL LIABILITIES AND EQUITY:210,349,000213,666,000275,987,000197,294,000300,898,000

Income Statement (P&L) (USD)

3/31/2026
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating expenses(179,037,000)(178,205,000)(136,919,000)(110,403,000)(83,221,000)
Operating loss:(179,037,000)(178,205,000)(136,919,000)(110,403,000)(83,221,000)
Nonoperating income (expense)(111,298,000)24,677,00019,235,00019,306,00011,678,000
Investment income, nonoperating7,182,0008,268,000   
Gain (loss), foreign currency transaction, before tax3,471,000(1,032,000)3,686,000821,0001,990,000
Other nonoperating income1,380,000823,0004,878,0004,061,00040,000
Interest and debt expense(4,517,000)(4,479,000)(2,204,000)  
Loss from continuing operations before equity method investments, income taxes:(294,852,000)(158,007,000)(119,888,000)(91,097,000)(71,543,000)
Other undisclosed income from continuing operations before income taxes4,517,0004,479,0002,204,000  
Loss from continuing operations before income taxes:(290,335,000)(153,528,000)(117,684,000)(91,097,000)(71,543,000)
Income tax expense (benefit)2,473,000(1,594,000)(780,000)(408,000)(199,000)
Loss from continuing operations:(287,862,000)(155,122,000)(118,464,000)(91,505,000)(71,742,000)
Loss before gain (loss) on sale of properties:(71,742,000)
Net loss attributable to parent:(287,862,000)(155,122,000)(118,464,000)(91,505,000)(71,742,000)
Undistributed earnings (loss) allocated to participating securities, basic     
Net loss available to common stockholders, basic:(287,862,000)(155,122,000)(118,464,000)(91,505,000)(71,742,000)
Other undisclosed net loss available to common stockholders, diluted     
Net loss available to common stockholders, diluted:(287,862,000)(155,122,000)(118,464,000)(91,505,000)(71,742,000)

Comprehensive Income (USD)

3/31/2026
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Net loss:(287,862,000)(155,122,000)(118,464,000)(91,505,000)(71,742,000)
Comprehensive loss:(287,862,000)(155,122,000)(118,464,000)(91,505,000)(71,742,000)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent1,405,000732,000(59,000)(25,707,000)(5,745,000)
Comprehensive loss, net of tax, attributable to parent:(286,457,000)(154,390,000)(118,523,000)(117,212,000)(77,487,000)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: